Nutex Health (NUTX) Cash from Financing Activities (2012 - 2026)

Nutex Health has disclosed Cash from Financing Activities across 14 years of filings, most recently posting -$49.5 million for Q1 2026.

• Cash from Financing Activities for Q1 2026 came in at -$49.5 million, down 627.38% year-over-year; the trailing twelve-month figure through Mar 2026 was -$140.7 million (down 1133.33% YoY), and the FY2025 annual result was -$97.9 million, down 9077.91% from the prior year.
• Cash from Financing Activities came in at -$49.5 million for Q1 2026 at Nutex Health, down from -$45.8 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $5.7 million in Q1 2024 to a low of -$49.5 million in Q1 2026.
• The 5-year median for Cash from Financing Activities is -$4.3 million (2023), against an average of -$11.6 million.
• Across the five-year window, Cash from Financing Activities tumbled 7144.95% in 2022 and surged 137.74% in 2023, its largest moves.
• Nutex Health's Cash from Financing Activities stood at -$14.8 million in 2022, then jumped by 73.47% to -$3.9 million in 2023, then gained by 23.72% to -$3.0 million in 2024, then slumped by 1433.52% to -$45.8 million in 2025, then slipped by 8.21% to -$49.5 million in 2026.
• The last three Cash from Financing Activities figures came in at -$49.5 million (Q1 2026), -$45.8 million (Q4 2025), and -$29.9 million (Q3 2025), per Business Quant data.